Who
Martin Wilson
General Counsel
Company insider
Files Form 4 as: General Counsel, Rocket Pharmaceuticals; General Counsel, Teligent.
In numbers
- Trades disclosed
- 56
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $1.0M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 25 Apr 2017
- Last trade
- 11 Sep 2026
- Last filed
- 15 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 15 Sep 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $256K75,364 at $3.40 | filing |
| 11 Sep 2026filed 15 Sep 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $256K75,364 at $3.40 | filing |
| 18 Aug 2026filed 20 Aug 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $2,133631 at $3.38 | filing |
| 18 Aug 2026filed 20 Aug 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $2,133631 at $3.38 | filing |
| 13 Aug 2026filed 17 Aug 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $12K3,493 at $3.38 | filing |
| 13 Aug 2026filed 17 Aug 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $12K3,493 at $3.38 | filing |
| 19 May 2026filed 21 May 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1,995662 at $3.01 | filing |
| 19 May 2026filed 21 May 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $1,993662 at $3.01 | filing |
| 13 May 2026filed 14 May 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $12K3,361 at $3.61 | filing |
| 13 May 2026filed 14 May 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $12K3,361 at $3.61 | filing |
| 18 Feb 2026filed 20 Feb 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $4,5931,376 at $3.34 | filing |
| 18 Feb 2026filed 20 Feb 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $4,5961,376 at $3.34 | filing |
| 13 Feb 2026filed 18 Feb 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $41K12,253 at $3.31 | filing |
| 13 Feb 2026filed 18 Feb 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $41K12,253 at $3.31 | filing |
| 11 Feb 2026filed 13 Feb 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —311,813 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —468,187 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —468,187 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —311,813 at $0.00 | filing |
| 18 Nov 2025filed 20 Nov 2025 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $4,9051,646 at $2.98 | filing |
| 3 Nov 2025filed 10 Nov 2025 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
News
Rocket Pharmaceuticals (NASDAQ:RCKT) General Counsel Martin Wilson Sells 75,364 Shares of Stockdailypolitical.com · 16 Sep 2026Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Crosses Below Fifty Day Moving Average – Should You Sell?RCKT · dailypolitical.com · 22 Oct 2026
1 headline in the last 90 days name Martin Wilson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.